Centessa Pharmaceuticals plc to Post FY2023 Earnings of Per Share, Leerink Partnrs Forecasts
CNTA Stock | USD 17.12 0.17 1.00% |
About 51% of Centessa Pharmaceuticals' investors are presently thinking to get in. The analysis of the overall investor sentiment regarding Centessa Pharmaceuticals PLC suggests that some traders are interested. The current market sentiment, together with Centessa Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Centessa Pharmaceuticals stock news signals to limit their universe of possible portfolio assets.
Centessa |
Centessa Pharmaceuticals plc Analysts at Leerink Partnrs raised their FY2023 EPS estimates for Centessa Pharmaceuticals in a research report issued to clients and investors on Monday, November 13th. Leerink Partnrs analyst D. Risinger now anticipates that the company will post earnings of per share for the year, up from
Read at thelincolnianonline.com
Centessa Pharmaceuticals Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Centessa Pharmaceuticals can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Centessa Pharmaceuticals Fundamental Analysis
We analyze Centessa Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Centessa Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Centessa Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Working Capital
Working Capital Comparative Analysis
Centessa Pharmaceuticals is currently under evaluation in working capital category among its peers. Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
Centessa Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Centessa Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Centessa Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Centessa Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
Centessa Pharmaceuticals Related Equities
NAMSW | NewAmsterdam Pharma | 2.00 | ||||
OPT | Opthea | 1.62 | ||||
EWTX | Edgewise Therapeutics | 1.33 | ||||
IRON | Disc Medicine | 0.75 | ||||
NUVL | Nuvalent | 0.51 | ||||
STRO | Sutro Biopharma | 0.36 | ||||
TARS | Tarsus Pharmaceuticals | 0.04 | ||||
GNFT | Genfit | 0.25 | ||||
TRDA | Entrada Therapeutics | 0.74 | ||||
CRNX | Crinetics Pharmaceuticals | 1.39 | ||||
LRMR | Larimar Therapeutics | 2.10 | ||||
HLVX | Hillevax | 2.55 | ||||
CGEM | Cullinan Oncology | 2.81 | ||||
GLUE | Monte Rosa | 3.52 | ||||
MLYS | Mineralys Therapeutics, | 4.60 | ||||
DSGN | Design Therapeutics | 4.62 | ||||
ERAS | Erasca | 4.95 | ||||
CCCC | C4 Therapeutics | 5.58 | ||||
IPSC | Century Therapeutics | 7.74 |
Complementary Tools for Centessa Stock analysis
When running Centessa Pharmaceuticals' price analysis, check to measure Centessa Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Centessa Pharmaceuticals is operating at the current time. Most of Centessa Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Centessa Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Centessa Pharmaceuticals' price. Additionally, you may evaluate how the addition of Centessa Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
CEOs Directory Screen CEOs from public companies around the world | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |